$3.19
-0.07-2.15%
At Close: -
$3.45
0.268.15%
After Hours: 7:52 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for NeuroBo Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.